Louise Parke

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Allergic Rhinitis

Placebo Controlled

Top Venues

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Charlotte Gotthard Mortz, Louise Parke, Helene M Rasmussen, Henrik Fomsgaard Kjaer, Carsten Bindslev-Jensen
A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy. Allergy 79 (4) (2024)
Charlotte Gotthard Mortz, Louise Parke, Helene M Rasmussen, Henrik Fomsgaard Kjaer, Carsten Bindslev-Jensen
A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy. Allergy 79 (4) (2024)
Louise Parke, Henrik Fomsgaard Kjaer, Susanne Halken, Carsten Bindslev-Jensen, Charlotte Gotthard Mortz
Factors associated with venom immunotherapy side-effects, re-sting reactions, and adherence in real-life. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2024)
Charlotte Gotthard Mortz, Louise Parke, Helene M Rasmussen, Henrik Fomsgaard Kjaer, Carsten Bindslev-Jensen
A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy. Allergy (2024)
Louise Parke, Henrik Fomsgaard Kjaer, Susanne Halken, Carsten Bindslev-Jensen, Charlotte Gotthard Mortz
Factors associated with venom immunotherapy side-effects, re-sting reactions, and adherence in real-life. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 54 (5) (2024)
Charlotte Gotthard Mortz, Louise Parke, Helene M Rasmussen, Henrik Fomsgaard Kjaer, Carsten Bindslev-Jensen
A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy. Allergy 79 (4) (2024)
Charlotte Gotthard Mortz, Louise Parke, Helene M Rasmussen, Henrik Fomsgaard Kjaer, Carsten Bindslev-Jensen
A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy. Allergy 79 (4) (2024)